Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

Drug makers on why public funds not enough for vaccines

Charlotte Kilpatrick
December 17, 2020
Share
bad taste

Counsel from BMS and Oxford say COVID has shown why collaboration between public institutions and pharma companies is essential for drug development

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Tags

IP StrategyNewsInternationalPatents
kilpatrick-charlotte-300px.png
Charlotte Kilpatrick
Reporter Managing IP
Contact
Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.
more from across site and ros bottom lb

More from across our site

Berlin / Germany - September 22, 2019: Sanofi Germany - Berlin b
Counsel predict Sanofi victory in SCOTUS enablement case
Significant changes to the standard of law are unlikely, say sources, who note that some justices seemed sceptical that the parties disagreed on the legal standard
Rani Mehta, March 29, 2023
Australian HC.jpeg
Counsel: Australian TM edict could weaken big brands’ power
Sources say the High Court of Australia’s ruling that reputation is immaterial in trademark infringement cases could stop famous brands from muscling out smaller players
Sukanya Sarkar, March 29, 2023
retro banner with red vintage typewriter with a blank sheet of p
US lawmakers blast patent thickets in letter to USPTO director
Members from both sides of the US House of Representatives wrote to USPTO director Kathi Vidal on Friday, March 24, expressing their concern about “patent thicketing.”
Rani Mehta, March 29, 2023
Charles Hoskin, Head of Brand Protection, Shopee.jpg
Good faith goes a long way, says Shopee brand protection head
Charles Hoskin of Singaporean e-commerce platform Shopee, who made the jump from a luxury brand, says honest conversations and collaborations are key to combatting counterfeiting
Sukanya Sarkar, March 29, 2023
Adam Williams.jpg
IP will benefit from government reshuffle: UKIPO CEO
Adam Williams speaks to Managing IP about the legacy of Brexit and why IP has sometimes got ‘lost in the noise’ at Westminster
Rory O’Neill, March 29, 2023
hand over a generic manual
Design patent lawyers want more from USPTO guidance
Lawyers wish the latest manual had more details on Federal Circuit cases and that training materials for design patent examiners were online
Rani Mehta, March 28, 2023
ITCTrendsCOVER.jpg
Three ITC trends shaping IP investigations
Counsel are eying domestic industry, concurrent PTAB proceedings and heightened scrutiny of cases before institution
Rani Mehta, March 24, 2023
JackDaniel's2023COVER.jpg
Jack Daniel’s SCOTUS hearing leaves counsel swaying
Jack Daniel’s has a good chance of winning its dispute over dog toys, but SCOTUS will still want to protect free speech, predict sources
Rani Mehta, March 24, 2023
AI img-min.jpeg
US Copyright Office’s AI guidance receives mixed reviews
AI users and lawyers discuss why the rulebook for registering AI-generated content may create problems and needs further work
Sukanya Sarkar, March 24, 2023
EPO
This week on MIP: EPO publishes G2/21, UK High Court backs Gilead
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Rory O’Neill, March 24, 2023